Independent Wealth Network Inc. lowered its position in Aflac Incorporated (NYSE:AFL – Free Report) by 2.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,327 shares of the financial services provider’s stock after selling 126 shares during the period. Independent Wealth Network Inc.’s holdings in Aflac were worth $551,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also modified their holdings of the company. Darwin Wealth Management LLC purchased a new position in shares of Aflac during the third quarter valued at $34,000. Raelipskie Partnership purchased a new position in Aflac during the third quarter valued at approximately $38,000. Covestor Ltd raised its stake in Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares in the last quarter. Kennebec Savings Bank purchased a new stake in Aflac during the third quarter worth $45,000. Finally, Catalyst Capital Advisors LLC bought a new stake in Aflac during the 3rd quarter valued at $51,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Aflac Price Performance
NYSE:AFL opened at $104.27 on Thursday. The stock has a 50 day moving average price of $106.24 and a 200 day moving average price of $105.72. The stock has a market cap of $57.92 billion, a PE ratio of 15.70, a P/E/G ratio of 2.13 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50.
Aflac Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.23%. This is an increase from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. Aflac’s payout ratio is 30.12%.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the company. Evercore ISI decreased their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Truist Financial increased their target price on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research report on Wednesday, January 8th. Barclays upped their target price on Aflac from $96.00 to $98.00 and gave the company an “underweight” rating in a research report on Monday, January 6th. Finally, Keefe, Bruyette & Woods dropped their price target on Aflac from $108.00 to $107.00 and set a “market perform” rating on the stock in a research note on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $102.07.
View Our Latest Research Report on AFL
Insider Activity at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.80% of the stock is owned by insiders.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
- Five stocks we like better than Aflac
- How to Start Investing in Real Estate
- 2 ETFs to Maximize Gains With Covered Call Strategies
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Small-Cap Stocks Insiders and Institutions Are Buying
- How to Invest in Blue Chip Stocks
- MaxCyte: Building the Future of Cell and Gene Therapy Innovation
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.